Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global Colorectal Cancer Diagnostics and Therapeutics Market Anticipates Impressive Growth Trajectory at a CAGR of ~9% by 2034 | DelveInsight

globenewswire.com
AGEN Listed as a key company in the colorectal cancer market, with no specific details on its performance or outlook. EXEL Mentioned as a key company in both colorectal cancer diagnostics/therapeutics and pipeline analysis, without specific performance indicators. ABBV Included as a key company in the colorectal cancer market, but the article does not provide specific sentiment or performance details. BMY Listed as a key company in the colorectal cancer market and pipeline analysis, without specific sentiment or performance data. MRK Mentioned as a key company in the colorectal cancer market and pipeline analysis, without specific sentiment or performance data. LYEL Listed as a key company in the colorectal cancer pipeline analysis, without specific sentiment or performance data. PFE Listed as a key company in the colorectal cancer pipeline analysis, without specific sentiment or performance data. BNTX Mentioned as a key company in the colorectal cancer pipeline analysis, without specific sentiment or performance data. NVDA Mentioned as a key company in the AI in Cancer Diagnostics market, without specific sentiment or performance data. IBM Listed as a key company in the AI in Cancer Diagnostics market, without specific sentiment or performance data. GEHC Listed as a key company in the AI in Cancer Diagnostics market, without specific sentiment or performance data. ABT Listed as a key company in the Molecular Diagnostics and Companion Diagnostics markets, without specific sentiment or performance data. QGEN Mentioned as a key company in the Molecular Diagnostics and Companion Diagnostics markets, without specific sentiment or performance data. TMO Listed as a key company in the Molecular Diagnostics and Companion Diagnostics markets, without specific sentiment or performance data. DHR Listed as a key company in the Molecular Diagnostics market, without specific sentiment or performance data. MYGN Mentioned as a key company in the Molecular Diagnostics and Companion Diagnostics markets, without specific sentiment or performance data. ILMN Listed as a key company in the Molecular Diagnostics and Companion Diagnostics markets, without specific sentiment or performance data. EXAS Mentioned as a key company in the Molecular Diagnostics market, without specific sentiment or performance data. INV Mentioned as a key company in the Companion Diagnostics market, without specific sentiment or performance data.

Global Colorectal Cancer Diagnostics and Therapeutics Market Anticipates Impressive Growth Trajectory at a CAGR of ~9% by 2034 | DelveInsight New York, USA, May 13, 2026 (GLOBE NEWSWIRE) -- Global Colorectal Cancer Diagnostics and Therapeutics Market Anticipates Impressive Growth Trajectory at a CAGR of ~9% by 2034 | DelveInsight

The global colorectal cancer diagnostics and therapeutics market is witnessing steady growth due to the rising prevalence of colorectal cancer, increasing awareness about early screening, and advancements in precision medicine. Growing adoption of non-invasive diagnostic technologies such as liquid biopsy, stool-based DNA tests, and molecular diagnostics is further accelerating market expansion. In therapeutics, the emergence of targeted therapies and immunotherapies is improving treatment outcomes and driving demand worldwide.

DelveInsight’s Colorectal Cancer Diagnostics and Therapeutics Market Insights report provides the current and forecast market analysis, individual leading colorectal cancer diagnostics and therapeutics companies’ market shares, challenges, colorectal cancer diagnostics and therapeutics market drivers, barriers, trends, and key colorectal cancer diagnostics and therapeutics companies in the market.

Colorectal Cancer Diagnostics and Therapeutics Market Summary

To read more about the latest highlights related to the colorectal cancer diagnostics and therapeutics market, get a snapshot of the key highlights @ https://www.delveinsight.com/sample-request/colorectal-cancer-diagnostics-and-therapeutics-market

Key Factors Contributing to the Rise in Growth of the Colorectal Cancer Diagnostics and Therapeutics Market

Get a sneak peek at the colorectal cancer diagnostics and therapeutics market dynamics @ Colorectal Cancer Diagnostics and Therapeutics Market Trends

Regional Colorectal Cancer Diagnostics and Therapeutics Market Insights

North America

Europe

Asia-Pacific

To know more about why North America is leading the market growth in the colorectal cancer diagnostics and therapeutics market, get a snapshot of the Colorectal Cancer Diagnostics and Therapeutics Market Share

Recent Developmental Activities in the Colorectal Cancer Diagnostics and Therapeutics Market

What are Colorectal Cancer Diagnostics and Therapeutics?

Colorectal cancer diagnostics and therapeutics encompass the range of medical technologies, tests, and treatment approaches used to detect, diagnose, monitor, and manage colorectal cancer, which affects the colon or rectum. Diagnostics include screening and detection methods such as fecal occult blood tests (FOBT), fecal immunochemical tests (FIT), colonoscopy, sigmoidoscopy, biopsy, molecular diagnostics, and imaging techniques like CT, MRI, and PET scans that help identify tumors and determine disease stage. Advances in biomarker testing and genetic profiling are also enabling earlier detection and personalized treatment planning. Therapeutics involve a combination of surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, and emerging precision medicine approaches aimed at improving survival outcomes and reducing disease recurrence. The growing focus on early screening programs, minimally invasive procedures, and novel targeted treatments is significantly transforming the colorectal cancer care landscape worldwide.

Colorectal Cancer Diagnostics and Therapeutics Market Assessment

Which MedTech key players in the colorectal cancer diagnostics and therapeutics market are set to emerge as the trendsetter explore @ Colorectal Cancer Diagnostics and Therapeutics Market Analysis

Table of Contents

Interested in knowing the colorectal cancer diagnostics and therapeutics market share by 2034? Click to get a snapshot of the Colorectal Cancer Diagnostics and Therapeutics Market Size

Related Reports

Colorectal Cancer Market

Colorectal Cancer Market Insights, Epidemiology, and Market Forecast – 2036 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key CRC companies, including Shanghai Henlius Biotech, Agenus, Tizona Therapeutics, Surgimab, Novartis, Bexion Pharmaceuticals, Syndax Pharmaceuticals, Exelixis, AbbVie, Tyligand Pharmaceuticals, Bristol Myers Squibb, Eisai, Bold Therapeutics, Takeda, Merck Sharp & Dohme, and others.

Colorectal Cancer Clinical Trial Analysis

Colorectal Cancer Pipeline Insight – 2026 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key CRC companies, including Exelixis, Mirati Therapeutics, Merck Sharp & Dohme LLC, Daiichi Sankyo Company, Inspirna, Lyell Immunopharma, Genentech, Cantargia AB, Arcus Biosciences, Inc., Neogap Therapeutics AB, Criterium, Inc., Daiichi Sankyo, Inc., Bristol-Myers Squibb, Celyad Oncology SA, Pfizer, Akeso, Menarini Group, Elpiscience (Suzhou) Biopharma, Ltd., BeyondBio Inc., Shanghai Henlius Biotech, Rottapharm Biotech, Innovative Cellular Therapeutics Inc., BioNTech SE, and others.

AI in Cancer Diagnostics Market

AI in Cancer Diagnostics Market Insights, Competitive Landscape, and Market Forecast – 2034 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key AI in cancer diagnostics companies, including iCAD, Inc., ibex-ai, Roche Diagnostics, Kheiron Medical Technologies Limited, MVision AI Inc., Siemens Healthineers AG, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., IBM Corporation, Azra AI, ConcertAI, PathAI, Median Technologies, Paige AI Inc., Therapixel, Flatiron, Freenome Holdings Inc., Onc.AI, Sonrai Analytics, and others.

Molecular Diagnostics Market

Molecular Diagnostics Market Insight, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key molecular diagnostics companies, including Hoffmann-La Roche Ltd., Hologic, Inc., bioMérieux SA, Abbott, QIAGEN, BD, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Danaher, Myriad Genetics, Inc., Agilent Technologies Inc., Illumina Inc., DiaSorin Inc., MDxHealth, Genetic Signatures, Biocartis, Exact Sciences Corporation, Amoy Diagnostics Co. Ltd., Molbio Diagnostics Pvt. Ltd., Savyon Diagnostics, and others.

Companion Diagnostics Market

Companion Diagnostics Market Insights, Competitive Landscape, and Market Forecast – 2034 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key companion diagnostics companies, including Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, Myriad Genetics, Inc., Abbott Laboratories, QIAGEN, BIOMÉRIEUX, Guardant Health Inc., Illumina, Inc., Pillar Biosciences, Inc., Leica Biosystems, Thermo Fisher Scientific Inc., Almac Group, NeoGenomics Laboratories, Invitae Corporation, 3D Medicines Corporation, ASURAGEN, INC. (Biotechne), Invivoscribe, Inc., Amoy Diagnostics Co., Ltd., Laboratory Corporation of America® Holdings, SAGA Diagnostics, and others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.